Article

Nidek receives CE Mark for excimer laser system

Lisbon, Portugal - Nidek Co., Gamagori, Japan, has received a CE Mark for its new and advanced refractive surgery laser system, the EC-5000CXIII. This regulatory milestone clears the way for NIDEK to commercialize and market the new laser platform for refractive surgery, throughout the world, especially in Europe and the Middle East, the company said.

Lisbon, Portugal - Nidek Co., Gamagori, Japan, has received a CE Mark for its new and advanced refractive surgery laser system, the EC-5000CXIII. This regulatory milestone clears the way for NIDEK to commercialize and market the new laser platform for refractive surgery, throughout the world, especially in Europe and the Middle East, the company said.

The CE Mark is an indication that a company has met essential health, safety, and environmental protection requirements detailed in 22 European Directives covering an array of products including medical devices. The CE Mark allows products to gain access to the European market, assuring physicians and patients of the safety of the product.

The new excimer laser platform, part of the Nidek NAVEX Quest System brings together advanced hardware modules - including 200 Hz eye tracking, torsion error detection and compensation, and multipoint laser delivery - along with innovative and proprietary software algorithms such as Nidek’s OATz, CATz, and OPDCAT for customized refractive surgery. The new laser system will work alongside Nidek’s advanced diagnostic platform, the OPD-Scan, and Final-Fit Software for performing customized and personalized refractive surgery procedures. 

“This approval brings a major milestone for Nidek, as we continue to deliver and commercialize new and innovative refractive surgery solutions to users around the world, especially in Europe and the Middle East,” said Motoki Ozawa, vice president of Nidek. “The new EC-5000CXIII excimer laser system brings together more than 10 years of research and development, and we are extremely proud and confident of the laser platform and the clinical outcomes users will get around the world.”

For more information, visit Nidek at Booth #227.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.